Subsys

Insys Therapeutics Inc (NASDAQ: INSY) Chairman Steven Meyer and board member Pierre Lapalme will resign "upon the execution of the agreements relating to the settlement with the U.S. Department of Justice," according to Reuters. Insys Therapeutics has agreed to pay $225 million and plead...

Insys Therapeutics Inc (NASDAQ: INSY), a pharmaceutical company that focuses on a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients called Subsys, reported its fourth quarter results Thursday which prompted Piper Jaffray to downgrade the stock. The Analyst...

On the same day President Donald Trump was expected to declare the national opioid epidemic a public health emergency, a Boston Federal Court charged John Kapoor, former CEO and chairman of the opioid producing Insys Therapeutics Inc (NASDAQ: INSY), along with six other executives with a...

Insys Therapeutics Inc (NASDAQ: INSY) is a commercial-stage specialty pharmaceutical company whose product Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients On Thursday, shares of Insys fell more than 3 percent after the Department of Justice...

Oppenheimer said in a note on Wednesday Insys Therapeutics Inc (NASDAQ: INSY) maintains its potential long-term upside. However, the firm said it prefers to be on the sidelines for now. DoJ Investigation Resolution Awaited Analyst Derek Archila said he continues to rate Insys at Perform, as...

Experienced traders know there are no sure things in the stock market. Sometimes, the exact time when it seems like things couldn’t get any worse for a stock is the time it has the most explosive short squeeze potential. That may very well be the case for Insys Therapeutics Inc (NASDAQ:...

Shares of Insys Therapeutics Inc (NASDAQ: INSY) plunged more than 18 percent on Thursday. Roddy Boyd of SIRF wrote a scathing research report on Thursday titled "Murder Incorporated: Insys Therapeutics" in which he argued the company is ‘in a great deal of trouble.'...

U.S. stocks recovered and posted strong gains as concerns over a military conflict involving Russia and Ukraine dissipated overnight. The Dow posted a triple digit point gain, recording its best day of the year. The S&P 500 surged to new all time highs of 1,876.23 while the Nasdaq hit new...